Astellas Pharma Inc. (4503.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.51T |
| Enterprise Value | 4.8T |
| P/E Ratio | 13.37 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 1.82 |
| Price/Book Ratio | 2.14 |
| Enterprise/Revenue | 1.96 |
| Enterprise/EBITDA | 7.06 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 2.14T |
| Revenue/Share | 1,191.26 |
| Gross Profit | 1.59T |
| EBITDA | 585.25B |
| Net Income | 291.54B |
| Diluted EPS | 162.22 |
Balance Sheet
| Total Cash | 281.61B |
| Total Cash/Share | 156.81 |
| Total Debt | 565.95B |
| Total Debt/Equity | 0.31 |
| Current Ratio | 1.17 |
| Book Value Per Share | 1,019.55 |
Price History
| 52-Week Change | 60.25 |
| 52-Week High | 2,717 |
| 52-Week Low | 1,343.5 |
| Moving Average 50 Days | 2,289.88 |
| Moving Average 200 Days | 2,126.35 |
Statistics
| Average Volume | 6.33M |
| Shares Outstanding | 1.79B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 78 |
| Trailing Annual Dividend Yield | 3.58 |
| Payout Ratio | 0.47 |
| Last Split Factor | 5:1 |
| Last Split Date | March 27, 2014 |
AD
